Stock listing
OTC:GSGTF Gensight Biologics SA Stock
US listing (OTC) of Gensight Biologics SA · home listing Euronext:SIGHT
Follow Gensight Biologics SA into a list and get an email when it puts out news.
Home listing price · EURONEXT:SIGHT
€0.076 EUR +0.005 (+7.4%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:SIGHT
- Day range
- €0.069 – €0.076 EUROct 20, 2026
- Volume
- 1.29M sharesOct 20, 2026
- Market cap
- €18.59M EURAt the close on Oct 20, 2026 · price × 245.3M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:SIGHT · Home | €0.076 EUR | +0.005 (+7.4%) | 1,288,749 | €0.071 | €0.076 | €0.069 | €0.071 | Close on Oct 20, 2026 |
| LSE:0RIM | €0.073 EUR | +0.002 (+2.1%) | 21,625 | €0.071 | €0.073 | €0.069 | €0.072 | Close on Oct 20, 2026 |
| Frankfurt:G49N | €0.051 EUR | -0.002 (-4.1%) | — | €0.051 | €0.051 | €0.051 | €0.054 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · EURONEXT:SIGHT · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.076 | +0.005 | +7.4% | €0.071 | €0.076 | €0.069 | 1,288,749 | |
| €0.071 | -0.002 | -2.2% | €0.073 | €0.074 | €0.070 | 683,873 | |
| €0.072 | -0.004 | -5.0% | €0.076 | €0.076 | €0.072 | 1,036,692 | |
| €0.076 | +0.005 | +7.3% | €0.071 | €0.076 | €0.069 | 2,443,235 | |
| €0.071 | +0.001 | +0.9% | €0.070 | €0.071 | €0.067 | 1,670,580 | |
| €0.070 | -0.004 | -5.8% | €0.075 | €0.075 | €0.070 | 1,139,033 | |
| €0.075 | -0.002 | -2.0% | €0.076 | €0.078 | €0.074 | 1,054,685 | |
| €0.076 | -0.004 | -5.4% | €0.080 | €0.080 | €0.075 | 1,210,309 | |
| €0.080 | -0.003 | -3.0% | €0.085 | €0.086 | €0.074 | 3,658,484 | |
| €0.083 | +0.003 | +3.5% | €0.080 | €0.087 | €0.080 | 1,619,455 | |
| €0.080 | 0.000 | -0.1% | €0.080 | €0.086 | €0.079 | 1,715,788 | |
| €0.080 | -0.004 | -4.3% | €0.084 | €0.084 | €0.072 | 2,933,860 | |
| €0.084 | -0.004 | -4.2% | €0.082 | €0.086 | €0.072 | 3,728,605 | |
| €0.087 | -0.012 | -12.1% | €0.095 | €0.099 | €0.087 | 2,108,978 | |
| €0.099 | -0.014 | -12.7% | €0.110 | €0.110 | €0.099 | 3,565,546 | |
| €0.114 | -0.005 | -4.2% | €0.120 | €0.120 | €0.114 | 965,335 | |
| €0.119 | -0.004 | -3.3% | €0.125 | €0.125 | €0.118 | 1,228,214 | |
| €0.123 | -0.009 | -7.0% | €0.133 | €0.135 | €0.121 | 2,687,582 | |
| €0.132 | +0.001 | +0.8% | €0.130 | €0.142 | €0.130 | 3,207,790 | |
| €0.131 | +0.015 | +12.9% | €0.118 | €0.131 | €0.117 | 2,320,182 | |
| €0.116 | +0.006 | +5.6% | €0.109 | €0.117 | €0.109 | 1,060,056 | |
| €0.110 | +0.001 | +1.1% | €0.108 | €0.111 | €0.107 | 672,619 | |
| €0.109 | -0.001 | -0.5% | €0.109 | €0.109 | €0.109 | 307,644 | |
| €0.109 | -0.002 | -1.6% | €0.111 | €0.111 | €0.108 | 775,748 | |
| €0.111 | -0.007 | -5.8% | €0.117 | €0.117 | €0.111 | 919,585 | |
| €0.118 | -0.001 | -0.5% | €0.119 | €0.124 | €0.116 | 1,196,489 | |
| €0.118 | +0.007 | +6.3% | €0.113 | €0.125 | €0.112 | 2,778,890 | |
| €0.111 | 0.000 | 0.0% | €0.112 | €0.112 | €0.110 | 726,563 | |
| €0.111 | -0.001 | -0.5% | €0.112 | €0.112 | €0.111 | 640,080 | |
| €0.112 | -0.002 | -2.1% | €0.112 | €0.114 | €0.111 | 919,496 | |
| €0.114 | +0.008 | +7.1% | €0.115 | €0.129 | €0.111 | 5,544,913 | |
| €0.107 | +0.001 | +0.6% | €0.107 | €0.107 | €0.105 | 291,311 | |
| €0.106 | -0.003 | -2.4% | €0.109 | €0.109 | €0.102 | 899,035 | |
| €0.109 | -0.008 | -7.2% | €0.118 | €0.118 | €0.098 | 4,681,897 | |
| €0.117 | -0.002 | -1.8% | €0.119 | €0.119 | €0.117 | 392,254 | |
| €0.119 | -0.004 | -2.9% | €0.125 | €0.125 | €0.119 | 1,325,516 | |
| €0.123 | -0.002 | -1.6% | €0.126 | €0.126 | €0.122 | 699,149 | |
| €0.125 | -0.001 | -1.0% | €0.127 | €0.127 | €0.124 | 2,021,011 | |
| €0.126 | +0.008 | +6.9% | €0.119 | €0.127 | €0.118 | 2,768,712 | |
| €0.118 | -0.002 | -2.0% | €0.121 | €0.121 | €0.117 | 834,284 | |
| €0.120 | -0.004 | -2.9% | €0.125 | €0.125 | €0.115 | 2,553,754 | |
| €0.124 | +0.009 | +8.0% | €0.118 | €0.134 | €0.115 | 4,719,570 | |
| €0.115 | +0.010 | +9.1% | €0.105 | €0.118 | €0.102 | 2,580,289 | |
| €0.105 | -0.003 | -2.6% | €0.108 | €0.108 | €0.103 | 993,428 | |
| €0.108 | +0.003 | +3.3% | €0.104 | €0.111 | €0.098 | 2,495,577 | |
| €0.105 | -0.009 | -8.2% | €0.118 | €0.119 | €0.102 | 2,721,336 | |
| €0.114 | +0.017 | +16.9% | €0.098 | €0.125 | €0.098 | 10,186,213 | |
| €0.098 | +0.010 | +11.9% | €0.087 | €0.098 | €0.087 | 4,441,608 | |
| €0.087 | +0.002 | +2.8% | €0.085 | €0.087 | €0.084 | 442,864 | |
| €0.085 | +0.000 | +0.1% | €0.085 | €0.085 | €0.084 | 474,352 | |
| €0.085 | -0.002 | -1.7% | €0.086 | €0.086 | €0.084 | 784,399 | |
| €0.086 | -0.002 | -2.2% | €0.087 | €0.087 | €0.085 | 719,712 | |
| €0.088 | 0.000 | -0.3% | €0.088 | €0.088 | €0.087 | 331,901 | |
| €0.088 | +0.001 | +1.6% | €0.087 | €0.088 | €0.085 | 1,009,401 | |
| €0.087 | +0.001 | +1.0% | €0.086 | €0.090 | €0.084 | 1,527,298 | |
| €0.086 | +0.002 | +2.4% | €0.085 | €0.086 | €0.084 | 1,235,659 | |
| €0.084 | +0.002 | +2.9% | €0.082 | €0.084 | €0.082 | 1,073,838 | |
| €0.082 | -0.001 | -1.6% | €0.083 | €0.083 | €0.082 | 535,652 | |
| €0.083 | +0.001 | +1.1% | €0.082 | €0.084 | €0.082 | 459,607 | |
| €0.082 | 0.000 | -0.2% | €0.082 | €0.083 | €0.082 | 272,453 | |
| €0.082 | 0.000 | -0.1% | €0.082 | €0.083 | €0.082 | 113,330 | |
| €0.082 | +0.000 | +0.1% | €0.082 | €0.082 | €0.082 | 185,127 | |
| €0.082 | -0.001 | -1.7% | €0.082 | €0.083 | €0.082 | 401,111 | |
| €0.084 | +0.002 | +3.0% | €0.083 | €0.084 | €0.083 | 566,621 | |
| €0.081 | -0.001 | -1.2% | €0.081 | €0.081 | €0.081 | 187,107 | |
| €0.082 | +0.001 | +0.6% | €0.082 | €0.082 | €0.082 | 80,103 | |
| €0.082 | -0.001 | -0.6% | €0.082 | €0.082 | €0.082 | 118,394 |
- Ticker
- OTC:GSGTF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders
Latest deck · May 19, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides
Latest news
GenSight Biologics Announces the Closing of its €1.0 Million Fundraising Supported by Existing Shareholders
Oct 16, 2026
Closed €0.071 (-2.2%) on Oct 19, 2026
Gensight Biologics and the 15-20 National Hospital Announce NEJM Publication on GS030 Phase 1/2 Trial Results in Late-Stage Retinitis Pigmentosa
Oct 8, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Announces a Successful €1.0 Million Fundraising Supported by Existing Shareholders
Oct 8, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Reports Cash Position as of September 30, 2026
Oct 7, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics S A Reports Cash Position as of September 30, 2026
Oct 7, 2026
Closed €0.08 (-3.0%) on Oct 8, 2026
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
Sep 30, 2026
Closed €0.099 (-12.7%) on Sep 30, 2026
GenSight Biologics publie ses résultats financiers du premier semestre 2026 et fait un point sur son activité
Sep 30, 2026
Closed €0.099 (-12.7%) on Sep 30, 2026
GenSight Biologics Provides September 2026 Business Updates
Sep 8, 2026
Closed €0.114 (+7.1%) on Sep 8, 2026
GenSight Biologics Reports Cash Position as of June 30, 2026, and Provides Business Updates
Jul 8, 2026
Closed €0.083 (-1.7%) on Jul 9, 2026
Financings
Private placement of ordinary shares, pre-funded warrants and investor warrants
Oct 16, 2026
Closed: €1M in the latest tranche · €0.077 a share · Warrants at €0.0497 for 60 months
Buyers: Heights Capital; Invus
Use of proceeds: Operating activities and working capital pending the structural financing of the RECOVER Phase III trial
Decks
Shareholder Meeting (May 2026)
Shareholder meeting · 59 slides · May 19, 2026
Investor Presentation (May 2025)
Investor deck · 26 slides · May 2025
Investor Presentation (September 2024)
Investor deck · 22 slides · September 2024
Investor Presentation (October 2023)
Investor deck · 26 slides · October 2023
Gensight Biologics SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 36 in the last 12 months · 49 in all · newest Oct 16, 2026 · oldest 2025
- Decks
- 9 decks · latest May 19, 2026
Where Gensight Biologics SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:SIGHT · Home listing | Euronext | France | EUR |
| LSE:0RIM | LSE | United Kingdom | EUR |
| gettex:G49N | gettex | Germany | EUR |
| LS Exchange:A2ANGZ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2ANGZ | Lang & Schwarz | Germany | EUR |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| OTC:GSGTF · This page | OTC | United States | USD |
| Aquis:SIGHTP | Aquis | United Kingdom | EUR |
| Dusseldorf:G49N | Dusseldorf | Germany | EUR |
| Frankfurt:G49N | Frankfurt | Germany | EUR |
| Hamburg:G49N | Hamburg | Germany | EUR |
| Munich:G49N | Munich | Germany | EUR |
| Stuttgart:G49N | Stuttgart | Germany | EUR |
| Turquoise:SIGHTP | Turquoise | United Kingdom | EUR |
Log in to ask 6ix AI your own questions about Gensight Biologics SA.